Diana Retana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Diana Retana has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Adolfo de la Lama Zaragoza
23 shared publicationsAlejandra Londoño Quiroz
23 shared publications- Alejandro Antón-Fernández
Centro de Biología Molecular Severo Ochoa (UAM-CSIC), Nicolás Cabrera, 1, Cantoblanco, Madrid 28049, Spain
23 shared publications - Amanda Sierra
Achucarro Basque Center for Neuroscience
23 shared publications - Ana Cayuela López
Biocomputing Unit, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
23 shared publications Ana González Piñeiro
23 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Survival analysis of the 37-gene signature derived from CD74+ microglia/macrophages across TCGA primary tumors cohorts
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Survival analysis of the 37-gene signature derived from CD74+ microglia/macrophages across TCGA primary tumors cohorts
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces PD-L1 expression in CD74+ from patient-derived organotypic cultures
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces PD-L1 expression in CD74+ from patient-derived organotypic cultures
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 14 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Patient-derived organotypic cultures (PDOC) treated with Ibudilast
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 14 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Patient-derived organotypic cultures (PDOC) treated with Ibudilast
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces brain metastasis in vivo without comprising the viability of cancer cells in vitro
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces brain metastasis in vivo without comprising the viability of cancer cells in vitro
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reverts the protumorigenic signature of CD74+ microglia/macrophages in vivo
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reverts the protumorigenic signature of CD74+ microglia/macrophages in vivo
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Gene set enrichment analysis of CD74+ microglia/macrophages
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Gene set enrichment analysis of CD74+ microglia/macrophages
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of marker genes defining each CD45⁺ immune cell population identified by single-cell RNA-seq
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of marker genes defining each CD45⁺ immune cell population identified by single-cell RNA-seq
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of flow cytometry antibodies
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of flow cytometry antibodies
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
CD74+ cells are mainly BMDM with transcriptional enrichment in OXPHOS pathway
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
CD74+ cells are mainly BMDM with transcriptional enrichment in OXPHOS pathway
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 18 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Upregulated pathways in the CD74+ myeloid clusters vs CD74- myeloid clusters
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 18 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Upregulated pathways in the CD74+ myeloid clusters vs CD74- myeloid clusters